A A Acheampong

Summary

Affiliation: Allergan Inc
Country: USA

Publications

  1. ncbi Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs
    A A Acheampong
    Allergan, Irvine, CA 92715, USA
    Curr Eye Res 18:91-103. 1999
  2. ncbi Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes
    Andrew A Acheampong
    Allergan, Inc, Irvine, California 42623 9534, USA
    Drug Metab Dispos 30:421-9. 2002
  3. ncbi Formulation effects on ocular absorption of brimonidine in rabbit eyes
    Andrew A Acheampong
    Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc, Irvine, California 92623 9534, USA
    J Ocul Pharmacol Ther 18:325-37. 2002
  4. ncbi Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits
    A A Acheampong
    Department of Pharmacokinetics, Allergan, Inc, Irvine, California, USA
    J Ocul Pharmacol Ther 11:489-502. 1995
  5. ncbi Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits
    Jennifer Q Dong
    Departments of Pharmacokinetics and Drug Metabolism, Allergan, Inc, Irvine, CA, USA
    J Ocul Pharmacol Ther 20:285-92. 2004

Collaborators

  • M E Stern
  • Jennifer Q Dong
  • Diane Tang-Liu
  • Devin F Welty
  • Scott M Whitcup
  • Darius M Babusis

Detail Information

Publications5

  1. ncbi Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs
    A A Acheampong
    Allergan, Irvine, CA 92715, USA
    Curr Eye Res 18:91-103. 1999
    ..To determine the ocular pharmacokinetics of cyclosporin A after topical ophthalmic administration...
  2. ncbi Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes
    Andrew A Acheampong
    Allergan, Inc, Irvine, California 42623 9534, USA
    Drug Metab Dispos 30:421-9. 2002
    ..The brimonidine levels achieved at the retina are relevant for neuroprotection models...
  3. ncbi Formulation effects on ocular absorption of brimonidine in rabbit eyes
    Andrew A Acheampong
    Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc, Irvine, California 92623 9534, USA
    J Ocul Pharmacol Ther 18:325-37. 2002
    ..In conclusion, 0.2% Brimonidine-Purite was 1.4 and 1.5 times more ocularly bioavailable in rabbits than 0.2% Alphagan and 0.2% Brimonidine-PF, respectively...
  4. ncbi Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits
    A A Acheampong
    Department of Pharmacokinetics, Allergan, Inc, Irvine, California, USA
    J Ocul Pharmacol Ther 11:489-502. 1995
    ..The low availability of levobunolol in the posterior segment as compared to timolol may be a key advantage for levobunolol in producing less adverse effect on blood flow in the choroid-retina and optic nerve...
  5. ncbi Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits
    Jennifer Q Dong
    Departments of Pharmacokinetics and Drug Metabolism, Allergan, Inc, Irvine, CA, USA
    J Ocul Pharmacol Ther 20:285-92. 2004
    ..20% at a pH of 6.4; (2) BAK-preserved brimonidine tartrate 0.15% at a pH of 6.4, and (3) Purite((R))-preserved brimonidine tartrate 0.15% at a pH of 7.3...